Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,437
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
for
Attention Deficit Disorder With Hyperactivity (ADHD)
Location: Austin TX, Little Rock AR, Decatur GA, Largo FL,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 65
Code: NCT07755410
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
for
Bladder Cancer, Urinary Bladder Neoplasms
Location: Austin TX, Myrtle Beach SC, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07222488
Phase 1, Phase 2, Recruiting
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
for
Prostate Cancer
Location: Austin TX, Atlanta GA, Portland OR
Sponsor: Blue Earth Diagnostics
Sex: Male
Age: 18+
Code: NCT07569926
Recruiting
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Austin TX, Houston TX, Dallas TX, Little Rock AR,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Austin TX, Houston TX, Dallas TX, Little Rock AR,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor